A

Accenture

Advises businesses and runs their technology

Visual Designer – Creative Lead - Life Sciences Industry

Full-TimeUpdated on 10/14/2026
No salary listed
Senior, Expert
Bachelor's
Heredia Province, Belén, Costa Rica
Hybrid
Art, Graphics & AnimationGraphic Design

About the job

Requirements
  • The role requires 8–10 years of relevant experience in visual or graphic design and creative team management, preferably in pharmaceutical, healthcare, or biotech creative agencies.
  • Proven experience in pharmaceutical art direction or design within creative or advertising agencies, including agency-of-record and product-launch experience is required.
  • At least 5 years of experience in a client-facing creative role with strong presentation skills is required.
  • Experience driving user-centered design processes and rapid prototyping, from sketching to digital prototypes, is required.
  • Advanced proficiency in Adobe Creative Suite, including Photoshop, Illustrator, XD, and InDesign, is required.
  • Advanced proficiency in Figma and generative AI tools is required.
  • Advanced proficiency in Microsoft Office, including PowerPoint, Word, and Excel, is required.
  • Strong knowledge of user interface and user experience principles, including user experience, design thinking, interaction design, accessibility design, usability testing, and competitive analysis, is required.
  • Working knowledge of Agile, Waterfall, or other project methodologies is required.
  • Scientific literacy, including the ability to read and interpret dense clinical trial data and medical content, is required.
  • Deep familiarity with pharmaceutical promotional review processes, including OPDP and MLR, is required.
  • Strong understanding of omnichannel campaign delivery for healthcare professional and patient audiences is required.
  • A strong portfolio demonstrating aesthetic and strategically creative solutions across multiple formats and channels is required.
  • Excellent oral and written communication skills in English and Spanish are required for LATAM and North America clients.
  • Strong interpersonal skills for requirements gathering and communication across teams, workstreams, and clients are required.
Responsibilities
  • Lead and own creative solutions research and development, creative strategy, concept development, and visual articulation for integrated campaigns across print, digital, social, experiential, and video.
  • Build marketing concepts and scientific narratives for product launches, multichannel advertising, and digital platforms.
  • Translate strategic insights into visual ideas that elevate client brands.
  • Partner with copy leads to drive cohesive creative thinking across deliverables.
  • Direct the creation of visual systems, campaign identities, and design approaches across formats.
  • Guide photo direction, illustration style, typography choices, color palettes, layout decisions, and data visualization.
  • Oversee quality control for visual deliverables, ensuring brand consistency and message alignment.
  • Apply accessibility best practices for color, contrast, and size across visual design decisions.
  • Provide hands-on direction to designers and art directors throughout the creative process.
  • Collaborate with medical, legal, and regulatory teams to ensure creative assets comply with pharmaceutical promotional review processes, including OPDP guidelines and MLR reviews.
  • Ensure creative innovation stays within pharmaceutical regulatory requirements.
  • Maintain scientific accuracy across promotional and educational materials.
  • Manage, mentor, and guide copywriters, designers, art directors, and external agencies.
  • Provide constructive feedback and model creative excellence to develop junior and mid-level talent.
  • Foster an inclusive, collaborative creative culture within the department.
  • Manage design leads and oversee resourcing, timelines, estimations, and forecasts across accounts.
  • Partner with Strategy, Account, Project Management, Medical Writers, Brand Managers, and Science Experts to ensure factual accuracy and strategic alignment.
  • Present creative concepts to internal stakeholders and external clients.
  • Contribute to new business efforts by developing conceptual directions and participating in pitch presentations.
  • Collaborate with production, user experience, and development teams on multichannel executions, leading generative AI practice and use of current tools.
  • Support brand planning and tactical development in partnership with cross-functional leads.
Desired Qualifications
  • Illustration specialization or data visualization skills are advantageous.
  • Experience in rare disease or oncology therapeutic areas is desired.
  • Experience in multinational pharmaceutical organizations or large healthcare agencies is desired.
  • Experience working with medical affairs and scientific communication teams is desired.
  • Knowledge of digital accessibility standards, including WCAG, and inclusive design principles is desired.
  • Familiarity with emerging design technologies, AI-assisted design tools, and production best practices is desired.
  • A track record of contributing to new business pitches and agency growth initiatives is desired.
  • A bachelor's degree in visual communications, graphic design, or a related field is desired.

About the company

Accenture advises large businesses and public agencies on strategy, builds their technology systems and runs ongoing operations. Its teams connect business planning with implementation, covering areas such as cloud migration, cybersecurity and customer experience. Consultants work with clients to redesign processes, while engineers integrate software from technology partners and maintain the resulting systems for multinational organizations. Clients pay for project work or continuing services, including application support and business processes such as finance and customer service. Accenture was founded in 1989 and has its headquarters in Dublin, Ireland.

Company Size

10,001+

Company Stage

IPO

Headquarters

Dublin, Ireland

Founded

1989

Get referred to Accenture

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Business demand grew: October 2026 results showed $74.2 billion annual revenue, up 5% in local currency.
  • Eligible US employees buy discounted stock: Accenture's purchase plan sells shares at 15% below market price.
  • Client relationships run deep: Accenture has worked with 195 of its top 200 customers for more than ten years.

What critics are saying

  • Bookings are not guaranteed revenue: most Accenture contracts let clients cancel quickly with little or no penalty.
  • Promotions require AI adoption: Accenture's CEO said in March 2026 that employees must use its tools effectively.
  • Federal hiring practices proved costly: Accenture settled discrimination allegations for $25 million in September 2026, without a liability finding.

What makes Accenture unique

  • Its AI platform switches models: AI Refinery selects among prebuilt models according to cost, performance and other requirements.
  • Accenture owns specialist Microsoft expertise: it cofounded the Microsoft-focused Avanade consultancy with the software maker.
  • Consulting includes creative agencies: Accenture Song owns businesses spanning advertising, digital product design and customer engagement.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Professional Development Budget

401(k) Retirement Plan

401(k) Company Match

Company News

Yahoo Finance
Oct 13th, 2026
Accenture shares up 77% from June low as Oct. 14 Investor Day nears

Accenture will hold an Investor Day on October 14, where it is expected to detail its long-term strategy, AI monetisation plans, growth guidance, and margin expansion goals. The event follows a rebound in its shares after fears that AI would erode traditional consulting work. The stock hit a low of $118.15 in June, down from a January high of $291.09. It has since gained nearly 77%, helped by fourth-quarter results on October 1 and an expanded collaboration with Dell Technologies. Fourth-quarter revenue rose 6% to $18.7 billion, and new bookings reached $22.2 billion. Accenture expects fiscal 2027 revenue growth of 3% to 6% in local currency. It raised its quarterly dividend by 5% to $1.71 per share, payable November 13, 2026. Its market capitalisation is about $139.6 billion.

Yahoo Finance
Oct 13th, 2026
Accenture buys UK data firm Sagacity, adding more than 140 AI customer intelligence specialists

Accenture has acquired Sagacity, a London-based data and customer intelligence firm, to strengthen Accenture Song's AI-powered customer services. The deal brings more than 140 professionals to Accenture Song's UK and Ireland operations. Terms were not disclosed. Founded in 2005 by Anita Dougall, Malka Townshend, and Harry Dougall, Sagacity offers data assets, AI-enabled technology, and customer intelligence expertise. Accenture says clients want to connect data, AI, and operations into unified programmes that deliver measurable results. The move targets industries with large customer bases, such as utilities, retail, banking, and telecommunications. "Sagacity's deep expertise and outcome-focused approach will enhance our ability to help clients turn insight into action," said Sohel Aziz, senior managing director of Accenture Song, UK and Ireland.

Associated Press
Oct 6th, 2026
TM Forum and Accenture launch industry's first AI trust certification for telcos

TM Forum has launched a multi-year Trustworthy AI programme with Accenture to help telecoms deploy autonomous operations with verifiable trust standards. The initiative will deliver the industry's first Trustworthy AI Governance Certification, providing a benchmark for trusted AI deployment. Recent TM Forum research found that whilst 72% of communications service providers believe their AI capabilities are trustworthy, only 14% can verify their claims. The programme aims to transform AI trust from aspiration into measurable operational capability. The certification will help organisations assess governance maturity, workforce readiness, and operational accountability needed to scale AI autonomously. It will operate through TM Forum's AI-Native Collaboration Studios, where telecoms operators, vendors, and partners will contribute real-world use cases to shape the framework.

Yahoo Finance
Oct 4th, 2026
Microsoft tops Accenture as AI infrastructure scales faster than consulting services

Accenture reported revenue of nearly $74.2 billion for fiscal year 2026, up 6.5% year-over-year, with net income of roughly $8.5 billion. The professional services firm serves approximately 9,000 clients globally with 814,000 employees. Microsoft generated revenue of nearly $331.8 billion in FY 2026, a 17.8% increase, with net income of approximately $133.7 billion. The company's net margin reached close to 40.3%. Both companies maintained a debt-to-equity ratio of approximately 0.3x. Microsoft's free cash flow reached nearly $67.0 billion, whilst Accenture's was roughly $11.6 billion. Accenture recently addressed a $25 million settlement with the Department of Justice regarding federal contracting practices. Microsoft faces securities fraud class action lawsuits involving AI and Copilot claims, alongside antitrust scrutiny and an IRS tax audit.

Yahoo Finance
Oct 2nd, 2026
Accenture surges 17% on Q4 beat with $18.7B revenue, but analyst warns stock fully priced at 15x forward earnings

Accenture shares surged 17% on Thursday after reporting strong fourth-quarter results. The company posted revenue of $18.7 billion, up 6% year-over-year, while earnings per share jumped 46% to $3.29. Management's full-year revenue growth forecast of 4.5% exceeded analyst expectations of 4%. Net bookings rose 4% to $22.2 billion. The company plans to return at least $9.5 billion to shareholders this financial year. However, TD Cowen analyst Bryan Bergin maintained a hold rating, citing concerns that the stock is fully priced at 15 times forward earnings. He cautioned that one strong quarter may represent a cyclical bounce rather than structural growth acceleration. Despite this, Wall Street remains optimistic, with a "moderate buy" consensus rating. Accenture currently offers a 3.05% dividend yield.